Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2022 07:33 ET | Source: Research and Markets

Global Pain Therapeutics Market to 2029 - Featuring Abbott Laboratories, AstraZeneca and GlaxoSmithKline Among Others

Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "Pain Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...
March 09, 2022 04:58 ET | Source: Research and Markets

Insights on the Cancer Pain Global Market to 2030 - Rising Healthcare Expenditure and Government Support Worldwide are Driving Growth

Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Pain Market, By Drug Type, By Disease Indication, Estimation & Forecast, 2017 - 2030" report has been added to...
June 21, 2013 13:44 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History

NORTHVALE, N.J., June 21, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...
June 19, 2013 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013

NORTHVALE, N.J., June 19, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
March 13, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment of Generic Hydromorphone Product

NORTHVALE, N.J., March 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of hydromorphone hydrochloride 8 mg tablets, the generic...